Obstacles Posed by the Tumor Microenvironment to T cell Activity: A Case for Synergistic Therapies

Kristin G Anderson1, Ingunn M Stromnes2, Philip D Greenberg1

  • 1Clinical Research Division, Fred Hutchinson Cancer Research Center, Mail Stop D3-100, P.O. Box 19024, Seattle, WA 98109, USA; Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; Departments of Medicine/Oncology and Immunology, University of Washington School of Medicine, Seattle, WA 98109, USA.

Cancer Cell
|March 16, 2017
PubMed

Insights

Solid tumors impair T cell function through a suppressive microenvironment and chronic signaling, hindering cancer immunity. Understanding these mechanisms is key to developing new cancer immunotherapies.

Area of Science:

  • Immunology
  • Oncology
  • Cancer Biology

Background:

  • Solid tumors create a suppressive microenvironment that impairs anti-tumor T cell responses.
  • Mechanisms include altered tumor cell signaling, inhibitory immune cells, metabolic constraints, and chronic T cell receptor stimulation.
  • Tumor-induced T cell dysfunction is a major barrier to effective cancer immunotherapy.

Purpose of the Study:

  • To review the multifaceted mechanisms of T cell dysfunction in solid tumors.
  • To highlight the influence of the tumor microenvironment on T cell trafficking and function.
  • To discuss potential scientific strategies for overcoming T cell exhaustion in cancer.

Main Methods:

  • Literature review focusing on T cell dysfunction in solid tumors.
  • Analysis of signaling pathways, cellular interactions, and metabolic factors within the tumor microenvironment.
  • Examination of T cell exhaustion driven by persistent antigen exposure.

Main Results:

  • Tumor cells alter signaling to foster a suppressive microenvironment.
  • Metabolic constraints and chronic T cell receptor signaling contribute to T cell exhaustion.
  • Specific examples from melanoma, pancreatic, and ovarian cancers illustrate these principles.

Conclusions:

  • Overcoming T cell dysfunction requires addressing the complex interplay between tumor and microenvironment.
  • Targeting suppressive pathways and restoring T cell function are crucial for enhancing cancer immunity.
  • Advances in understanding these hurdles offer promise for novel therapeutic approaches.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
16.8K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
85.4K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.7K